You can buy or sell OncoCyte and other stocks, options, ETFs, and crypto commission-free!
OncoCyte Corporation, also called OncoCyte, is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. Read More The company was founded in September 2009 and is headquartered in Alameda, CA.
52 Week High
52 Week Low
OncoCyte to Report Fourth Quarter and Full-Year 2018 Financial Results on Monday, April 1, 2019
ALAMEDA, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of cancer, announced today that it will release its financial and operating results for the fourth quarter and year ended December 31, 2018, on Monday, April 1, 2019, after the close of the U.S. financial markets. The Company will host a conference call on Monday, April 1, 2019, at 4:30 pm ET / 1:30 pm PT to discuss the results along with recent corp...
Expected Mar 27, After Hours